Pathologist-like explainable AI for interpretable Gleason grading in prostate cancer.

Gesa Mittmann1,2, Sara Laiouar-Pedari1, Hendrik A Mehrtens1

  • 1Division of Digital Prevention, Diagnostics and Therapy Guidance, German Cancer Research Center (DKFZ), Heidelberg, Germany.

Nature Communications
|October 8, 2025
PubMed
Summary

This study introduces an explainable AI for prostate cancer grading, improving Gleason score prediction accuracy. The AI uses pathologist-defined terms and soft labels for robust segmentation, aiding clinical decisions.

Related Concept Videos